Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0738 CHF | +1.10% | -1.60% | +60.43% |
May. 08 | Addex to Present at BioEURquity Europe 2024 | DJ |
Apr. 30 | European Equities Traded in the US as American Depositary Receipts Decline | MT |
Sales 2024 * | - | Sales 2025 * | 20M 22.01M | Capitalization | 9.47M 10.42M |
---|---|---|---|---|---|
Net income 2024 * | -6M -6.6M | Net income 2025 * | 13M 14.31M | EV / Sales 2024 * | - |
Net cash position 2024 * | 362K 399K | Net cash position 2025 * | 7.23M 7.95M | EV / Sales 2025 * | 0.11 x |
P/E ratio 2024 * |
-0.82
x | P/E ratio 2025 * |
0.35
x | Employees | 23 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 50.48% |
Latest transcript on Addex Therapeutics Ltd
1 day | +1.10% | ||
1 week | -1.60% | ||
Current month | +20.98% | ||
1 month | -61.16% | ||
3 months | -1.60% | ||
6 months | +47.01% | ||
Current year | +60.43% |
Managers | Title | Age | Since |
---|---|---|---|
Tim Dyer
FOU | Founder | 56 | 01-12-31 |
Lénaic Teyssédou
DFI | Director of Finance/CFO | 38 | 17-05-31 |
Vincent Lawton
CHM | Chairman | 75 | 09-04-15 |
Members of the board | Title | Age | Since |
---|---|---|---|
Jake Nunn
BRD | Director/Board Member | 53 | 18-05-31 |
Tim Dyer
FOU | Founder | 56 | 01-12-31 |
Vincent Lawton
CHM | Chairman | 75 | 09-04-15 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-13 | 0.0738 | +1.10% | 240,121 |
24-05-10 | 0.073 | -0.54% | 301,965 |
24-05-08 | 0.0734 | +3.38% | 296,261 |
24-05-07 | 0.071 | -5.33% | 493,677 |
Delayed Quote Swiss Exchange, May 13, 2024 at 11:30 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+60.43% | 10.33M | |
+26.37% | 44.96B | |
-1.01% | 42.65B | |
+46.00% | 41.85B | |
-5.31% | 29.04B | |
+9.34% | 26.08B | |
-21.69% | 19.03B | |
+6.23% | 12.75B | |
+26.99% | 12.06B | |
-3.38% | 11.75B |
- Stock Market
- Equities
- ADXN Stock